In case you missed any, read a recap of the episodes of OncLive On Air that aired in July 2026.
Commentary|Articles|April 25, 2025
Oncology Experts Preview Abstracts to Watch at the 2025 AACR Annual Meeting
Author(s)Ashling Wahner
Fact checked by: Chris Ryan
Experts from across oncology specialties highlight research being presented at the 2025 AACR Annual Meeting.
Advertisement
Advertisement
Ahead of the
Related to this article
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
The top 5 OncLive TV videos of the week cover insights in melanoma, prostate cancer, breast cancer, multiple myeloma, and small cell lung cancer.
The FDA approved RP1 plus nivolumab in advanced melanoma, granted olomorasib breakthrough status in KRAS G12C+ pancreatic cancer, and more.
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
The CLDN18.2/CD47 bispecific antibody spevatamig has received FDA fast track designation for advanced and metastatic biliary tract carcinoma.
Zipalertinib plus chemotherapy produced a statistically significant, clinically meaningful PFS improvement vs chemotherapy alone at a planned interim analysis.
T-DXd plus pertuzumab was approved in China as first-line treatment for unresectable or metastatic HER2-positive breast cancer.
Advertisement
Advertisement